IL17RB and breast cancer: A case-control study, performed on an independent cohort of (N-) BC patients, in order to compare the predictive value of HOXB13/IL17BR, MGI and BCI index, has shown that the three tests are associated with the risk of BC death and display a strong prognostic value in BC management [79].